Nigeria

The initiative supports broader efforts to improve tuberculosis detection as Nigeria approaches the final phase of its 2021–2026 National Strategic Plan.

NAFDAC released the public alert following a Notice of Concern from the WHO Prequalification service.

This strategic approach aligns with President Bola Tinubu’s broader vision to unlock the healthcare value chain by empowering local pharmaceutical industries.

The medical expert stressed that when chronic kidney disease is detected early, healthcare providers can effectively manage the condition and prevent its progression.

The Lassa Fever E2E Access Roadmap establishes a comprehensive, regionally driven approach that connects every critical stage in transitioning a vaccine from development to sustained, widespread use.

This move introduces advanced tools like the da Vinci robotic surgical system, promising to elevate medical care across the region.

NAFDAC’s decision came after assessing outcomes from these surgeries, which used the Toumai system manufactured by Shanghai MicroPort MedBot.

The study analysed more than 187,000 laboratory test results from 205 laboratories located in 14 African countries, including Nigeria, using samples collected between 2016 and 2019.

These landmark achievements highlight AMCE’s growing capability to deliver complex, life-saving procedures within Africa, reducing the long-standing need for patients to travel abroad for advanced medical treatments.

Through its wholly owned healthcare subsidiary, NSIA Advanced Medical Services Limited (MedServe), the Authority has partnered with GE HealthCare to launch an ambitious diagnostic services expansion program.